Atlas Trials

RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

Clinical trial NCT04485195 · COMPLETED

Trial details

NCT number
NCT04485195
Sponsor
Ottawa Hospital Research Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2021-06-17
Primary completion
2024-09-15
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.